Arvind Chopra News Today

Even though there are 60 million arthritis patients in India, the disease is yet to be considered a major non-communicable disease (NCD) by the authorities, experts said at a global conclave, here on Saturday.This was highlighted during a ...

This is for the first time that such appointments of research scientists from various related disciplines, including modern medicine, have been made to boost clinical research in Ayurveda, Yoga, and other related Ayush disciplines, They will work as Professor Chairs in the five selected and specific domains.

The meeting was attended by Heads of all Ayush National Institutions, Research, Councils and advisors of MoA, Chairman of NCSIM and NCH including five newly- distinguished appointed scientists Ayush Distinguished Scientist Chairs Dr Nandini K. Kumar (Interdisciplinary Clinical Research), Dr Arvind Chopra, (Public health and Epidemiology), Dr Sharmila Shekhar Mande (Ayurveda Biology and Basic Sciences), Dr Madhu Dikshit (Pharmaceutical Drug Development) and Dr. B.N. Gangadhar (Consciousness and C...

All India Institute of Ayurveda (AIIA) and Central Council for Research in Ayurvedic Sciences (CCRAS) on Wednesday jointly organised an interactive meet for research and education in Ayush with focus on R&D, Education and capacity building ...

The meeting was attended by Heads of all Ayush National Institutions, Research, Councils and advisors of MoA, Chairman of NCSIM and NCH including five newly- distinguished appointed scientists Ayush Distinguished Scientist Chairs Dr Nandini K. Kumar (Interdisciplinary Clinical Research), Dr Arvind Chopra, (Public health and Epidemiology), Dr Sharmila Shekhar Mande (Ayurveda Biology and Basic Sciences), Dr Madhu Dikshit (Pharmaceutical Drug Development) and Dr. B.N. Gangadhar (Consciousness and C...

Only 300 of around 65,000 COVID-19 patients who used Ayurvedic formulations needed hospitalisation and none of them died due to the pandemic, a top official of the Union Ministry of Ayush said here on Friday.

Industry > Industry monitor > Healthcare 29 April 2021 Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care. Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collabor...

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said. Share Updated: May 3, 2021, 08:08 PM IST AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday. Central Council for Research in Ayurvedic Sciences...

Poly Herbal Formulation AYUSH-64 Found Useful In Treatment Of Mild To Moderate COVID-19 Infection: AYUSH Ministry by Swarajya Staff - Apr 29, 2021 11:52 AM AYUSH-64 (Pic Via Twitter) The scientists of reputed research institutions of the country have found that AYUSH 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) under the Ministry of Ayush, is useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct t...